Oligodendrocytes show enriched expression of amyloid precursor protein and GABA B receptor isoform 1a
Samah Houmam1,2,3, Dominika Siodlak1, Meena Seshadri1,4
1Aging & Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 73104, USA.
Abstract:
Amyloid precursor protein (APP) is a type I transmembrane protein that undergoes proteolytic processing to generate amyloid-β, the main component of amyloid plaques found in brains with Alzheimer's disease. The proteolytic processing of APP also generates soluble APP alpha (sAPPα) which can modulate synaptic transmission and neurite outgrowth through the γ-aminobutyric acid type B receptor (GABABR). Whether GABABR mediates functions of sAPPα in other neural cell types such as glia remains unknown. sAPPα binds the R1a subunit isoform of GABABR1 which contains two sushi domains absent in R1b. It is unclear whether both GABABR1 isoforms are expressed equally across brain cell types. We determined relative RNA levels of the GABABR1a and 1b isoforms in oligodendrocytes, microglia, endothelial cells, astrocytes, and neurons in adult mice using two approaches. We developed a GABABR1 isoform-specific RNAseq analysis workflow to probe a publicly available dataset. We also isolated five cell types from a single mouse brain and performed RT-qPCR. We show that the GABABR1a and 1b isoforms are differentially expressed among cell types. GABABR1a expression was highest in oligodendrocytes and GABABR1b expression was highest in astrocytes, suggesting that sAPPα-mediated GABABR signaling may be most prominent in oligodendrocytes. We also confirmed that APP is expressed in all five cell types and showed that APP RNA levels are highest in oligodendrocytes. Together, our findings uncover cell type-specific expression of GABABR isoforms and highlight oligodendrocytes as a principal cell type for GABABR1a-mediated APP signaling, providing a foundation for future mechanistic studies.
More Related Videos
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology


